The Ozempic shortage is over, a big threat to off-brand weight loss drug sellers
In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, California. The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over,
Shortage of popular drugs Wegovy and Ozempic is over, FDA says.
The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.
FDA removes semaglutide from drug shortage list
The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can meet present and future demand, Novo Nordisk announced.On Feb. 21, the FDA updated its drug shortage list and listed the shortage of all doses of injectable semaglutide (Ozempic/Wegovy) as being resolved.
Yearslong Shortage of Popular Weight-Loss and Diabetes Drugs Is Resolved, FDA Says
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity treatments continue to improve
U.S. attorneys general forum urges FDA to act against counterfeit weight loss drugs
A bipartisan group of U.S. state and territory attorneys general is pressing the FDA to take prompt action against those threatening public health by marketing counterfeit forms of branded weight loss medications developed by Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY).
Medical News Today2d
Drug for diabetes and kidney disease may also lower heart attack, stroke risks
An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...
Scientists Identify Cellular “Switch” That May Reverse Diabetes
Mitochondrial stress disrupts insulin production in diabetes, but reversing the damage may restore β-cell function.
Drug Middlemen Lose Bid to Block FTC Case on Insulin Cost (1)
A federal judge in Missouri rejected three major pharmacy benefit managers’ push to pause the Federal Trade Commission’s ...
Rolling Out3d
Diabetes drugs show promise in reducing COPD complications
Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...
Knowridge3d
Common diabetes drug can also prevent heart and kidney diseases
The medication, known as sodium-glucose co-transporter 2 inhibitors (SGLT2is), is already used to lower blood sugar in people ...